VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
XRAYDENTSPLY SIRONA Inc.
$10.15$2.0B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksXRAYRevenue History

XRAY logoDENTSPLY SIRONA Inc. (XRAY) Revenue History

Annual and quarterly revenue from 1986 to present

TTM Revenue$3.68B▲ +$1.0M vs FY2025
YoY Growth+0.1%Slow
Q1 2026$880.0M+0.1% YoY · -8.4% QoQ
Revenue CAGR
3Y-2.1%
→
5Y+2.0%
→
10Y+3.2%
Growth decelerating ↓
Best Fiscal Year$4.23B (2021)
Best Quarter$1.11B (Q4 2019)
Revenue per Share$18.37
Revenue per Employee$263K

XRAY Revenue Over Time (1986–2025)

XRAY Revenue Growth History

26 of 35 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
1986—
1990+329.1%
1992+55.2%
1993+553.2%
1994-5.0%
1995+9.0%
1996+14.8%
1997+9.8%
1998+10.3%
1999+4.5%
2000+7.1%
2001+26.9%
2002+34.1%
2003+3.8%
2004+7.8%
2005+1.2%
2006+5.6%
2007+11.0%
2008+9.1%
2009-1.5%
2010+2.8%
2011+14.3%
2012+15.4%
2013+0.8%
2014-1.0%
2015-8.5%
2016+40.0%
2017+6.6%
2018-0.2%
2019+0.9%
2020-17.0%
2021+26.7%
2022-7.3%
2023+1.1%
2024-4.3%
2025-3.0%
FY1986 revenue growth
N/A
FY1990 revenue growth
+329.1%
FY1992 revenue growth
+55.2%
FY1993 revenue growth
+553.2%
FY1994 revenue growth
-5.0%
FY1995 revenue growth
+9.0%
FY1996 revenue growth
+14.8%
FY1997 revenue growth
+9.8%
FY1998 revenue growth
+10.3%
FY1999 revenue growth
+4.5%
FY2000 revenue growth
+7.1%
FY2001 revenue growth
+26.9%
FY2002 revenue growth
+34.1%
FY2003 revenue growth
+3.8%
FY2004 revenue growth
+7.8%
FY2005 revenue growth
+1.2%
FY2006 revenue growth
+5.6%
FY2007 revenue growth
+11.0%
FY2008 revenue growth
+9.1%
FY2009 revenue growth
-1.5%
FY2010 revenue growth
+2.8%
FY2011 revenue growth
+14.3%
FY2012 revenue growth
+15.4%
FY2013 revenue growth
+0.8%
FY2014 revenue growth
-1.0%
FY2015 revenue growth
-8.5%
FY2016 revenue growth
+40.0%
FY2017 revenue growth
+6.6%
FY2018 revenue growth
-0.2%
FY2019 revenue growth
+0.9%
FY2020 revenue growth
-17.0%
FY2021 revenue growth
+26.7%
FY2022 revenue growth
-7.3%
FY2023 revenue growth
+1.1%
FY2024 revenue growth
-4.3%
FY2025 revenue growth
-3.0%
DeclineStrong growth
↓ 2-year revenue declineBest: +553.2% (FY1993)Worst: -17.0% (FY2020)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q1 2026$880.0M+0.1%
Q4 2025$961.0M+6.2%
Q3 2025$904.0M-4.9%
Q2 2025$936.0M-4.9%
Q1 2025$879.0M-7.8%
Q4 2024$905.0M-10.6%
Q3 2024$951.0M+0.4%
Q2 2024$984.0M-4.3%
Seasonal Revenue Pattern (fiscal quarters)
Q1
23%
Q2
25%
Q3
25%
Q4
27%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown (FY 2022)

XRAY's revenue distribution by segment and geography for fiscal year 2022

By Product/Segment

Technologies And Equipment59.1%
Consumables Segment40.9%

By Geography

Europe42.8%
UNITED STATES32.1%
Other Foreign25.1%

XRAY Revenue Analysis (1986–2025)

Current Revenue & Growth

As of June 23, 2026, DENTSPLY SIRONA Inc. (XRAY) generated trailing twelve-month (TTM) revenue of $3.68 billion, reflecting modest growth of +0.1% year-over-year. The most recent quarter (Q1 2026) recorded $880.0 million in revenue, down 8.4% sequentially.

Historical Growth Trajectory

XRAY's 5-year compound annual growth rate (CAGR) stands at +2.0%, indicating moderate growth over time. The 3-year CAGR of -2.1% is below the 5-year average, signalling a growth deceleration in recent years. DENTSPLY SIRONA Inc.'s highest annual revenue of $4.23 billion was recorded in 2021.

Revenue by Segment

XRAY's revenue is primarily driven by Technologies And Equipment (59%), and Consumables Segment (41%). With over half of revenue concentrated in Technologies And Equipment, the company has a focused business model while developing other growth vectors.

Peer Comparison

Compared to Healthcare sector peers — including ALGN (+2.9% YoY), HSIC (+4.0% YoY), and NVST (+12.1% YoY) — XRAY has underperformed the peer group in revenue growth. Compare XRAY vs ALGN →

XRAY Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
XRAY logoXRAYCurrent$3.7B+0.1%+2.0%6.8%
ALGN logoALGN$4.0B+2.9%+10.3%15.3%
HSIC logoHSIC$13.2B+4.0%+5.4%5.7%
NVST logoNVST$2.7B+12.1%+7.1%8.3%
MMSI logoMMSI$1.5B+11.2%+9.5%12.2%
HOLX logoHOLX$4.1B+2.2%+1.7%17.4%
Best in groupLowest in group

XRAY Historical Revenue Data (1986–2025)

1–15 of 36 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$3.68B-3.0%$1.84B50.0%$252.0M6.8%
2024$3.79B-4.3%$1.96B51.6%$-879,000,000-23.2%
2023$3.96B+1.1%$2.09B52.6%$-85,000,000-2.1%
2022$3.92B-7.3%$2.13B54.2%$-937,000,000-23.9%
2021$4.23B+26.7%$2.35B55.5%$608.0M14.4%
2020$3.34B-17.0%$1.66B49.6%$-3,000,000-0.1%
2019$4.02B+0.9%$2.16B53.8%$353.0M8.8%
2018$3.99B-0.2%$2.07B51.9%$-958,100,000-24.0%
2017$3.99B+6.6%$2.19B54.8%$-1,585,300,000-39.7%
2016$3.75B+40.0%$2.00B53.4%$454.7M12.1%
2015$2.67B-8.5%$1.52B56.7%$375.2M14.0%
2014$2.92B-1.0%$1.60B54.7%$445.6M15.2%
2013$2.95B+0.8%$1.58B53.5%$419.2M14.2%
2012$2.93B+15.4%$1.56B53.1%$381.9M13.0%
2011$2.54B+14.3%$1.27B50.2%$300.7M11.9%
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

40+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XRAY — Frequently Asked Questions

Quick answers to the most common questions about buying XRAY stock.

Is XRAY's revenue growth accelerating or slowing?

XRAY revenue growth is slowing. TTM revenue is $3.7B, up +0.1% year-over-year — below the 5-year CAGR of +2.0%. The deceleration suggests maturing end-markets or increased competition.

What is XRAY's revenue history from 1986 to 2026?

DENTSPLY SIRONA Inc. (XRAY) revenue history spans 1986 to 2026. TTM revenue as of 2026 is $3.7B, growing at +0.1% YoY. The 5-year CAGR is +2.0%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is XRAY's long-term revenue growth rate (CAGR)?

DENTSPLY SIRONA Inc.'s 5-year revenue CAGR of +2.0% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +0.1% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for XRAY.

Why does XRAY's quarterly revenue fluctuate?

XRAY quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. DENTSPLY SIRONA Inc.'s revenue data from 1986 to 2026 shows full historical quarterly detail on this page.

How is XRAY's revenue distributed by segment?

XRAY reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does XRAY's revenue compare to industry peers?

DENTSPLY SIRONA Inc. (XRAY) with TTM revenue of $3.7B and +0.1% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.